SaNOtize Research and Development Corporation today announced that it has been granted approval by Health Canada to conduct a multi-Centre Phase II prevention and efficacy trial for a front-line antiviral prevention and early treatment for use against COVID-19.

SaNOtize Obtains Health Canada Approval to Commence Phase II Trial for Potential COVID-19 Therapy